Drugs / CCNU: Lomustin L01AD02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01614132 | Jan 2009 → Oct 2018 | adult medulloblastoma | University of Regensburg | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CCNU: Lomustin L01AD02 | “CCNU: Lomustin L01AD02” NCT01614132 ↗ |
| Known as | CCNU | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01614132 ↗ |
| Route | Oral | “75 mg/m2 CCNU oral” NCT01614132 ↗ |